Primary Biliary Cholangitis Market 2028 By Treatment Type, Distribution Channel and Geography | The Insight Partners

report image

Primary Biliary Cholangitis Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Treatment Type (Drugs, Liver Transplantation); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00005562 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Primary biliary cholangitis (PBC) previously known as Primary Biliary Cirrhosis, is a chronic liver disease that originates in the bile ducts. The bile ducts are damaged, as in primary biliary cirrhosis and harmful substances may build up in liver, which leads to irreversible scarring of liver tissue. PBC is considered as autoimmune disease in which body turn against own cells. The primary biliary cholangitis develop slowly.


The primary biliary cholangitis market is expected to grow in coming years owing to factors such as increase in research and development activities for development of medication, increasing number of patients suffering from primary biliary cholangitis and others. On the other hand increase in approvals of drugs to treat PBC by Food and Drug Administration (FDA) is likely to offer opportunities in market.


The "Global Primary Biliary Cholangitis Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of primary biliary cholangitis market with detailed market segmentation by treatment type, end user and geography. The global primary biliary cholangitis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading primary biliary cholangitis market players and offers key trends and opportunities in the market.


The global primary biliary cholangitis market is segmented on the basis of treatment type and end user. Based on treatment type, the market is segmented as drugs and liver transplantation. The drug segment is further classified into symptomatic relief treatment, ursodeoxycholic (UDCA) and obeticholic acid (ocaliva). Based on end user the primary biliary cholangitis market is segmented hospital pharmacies, retail pharmacies and online pharmacies.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global primary biliary cholangitis market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The primary biliary cholangitis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting primary biliary cholangitis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the primary biliary cholangitis market in these regions.

Get more information on this report :


The reports cover key developments in the primary biliary cholangitis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from primary biliary cholangitis market are anticipated to lucrative growth opportunities in the future with the rising demand for primary biliary cholangitis in the global market. Below mentioned is the list of few companies engaged in the primary biliary cholangitis market.

The report also includes the profiles of key primary biliary cholangitis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Zydus Pharmaceuticals, Inc.
  • Tagi Pharma, Inc.
  • Intercept Pharmaceuticals, Inc.
  • Amneal Pharmaceuticals LLC
  • Mylan N.V
  • Lannett
  • Hikma Pharmaceuticals PLC
  • Gemini Pharmaceuticals.
  • Bristol-Myers Squibb Company
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Zydus Pharmaceuticals, Inc.
2. Tagi Pharma, Inc.
3. Intercept Pharmaceuticals, Inc.
5. Amneal Pharmaceuticals LLC
6. Mylan N.V
7. Lannett
8. Hikma Pharmaceuticals PLC
9. Gemini Pharmaceuticals.
10. Bristol-Myers Squibb Company
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount